1-20 of 76
Bing Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Proteomics Meets Dose Response: A New Paradigm for Deciphering Drug Effects

Chenwei Wang, Bing Zhang
Journal: Cancer Research
Cancer Res (2024) 84 (16): 2572–2574.
https://doi.org/10.1158/0008-5472.CAN-24-2087
Published: 15 August 2024
View article titled, Proteomics Meets Dose Response: A New Paradigm for Deciphering Drug Effects
Open the PDF for Proteomics Meets Dose Response: A New Paradigm for Deciphering Drug Effects in another window
Journal Articles

Abstract PO4-06-08: ZP4 AS A NOVEL TARGET FOR CAR T CELL THERAPY IN TRIPLE NEGATIVE BREAST CANCER

Lauren Somes, Jonathan Lei, Paul Shafer, Xinpei Yi, Diego Chamorro, Emily Madaras, Michael Lewis, Bing Zhang, Valentina Hoyos
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO4-06-08.
https://doi.org/10.1158/1538-7445.SABCS23-PO4-06-08
Published: 02 May 2024
View article titled, Abstract PO4-06-08: ZP4 AS A NOVEL TARGET FOR CAR T CELL THERAPY IN TRIPLE NEGATIVE BREAST CANCER
Journal Articles

Abstract GS01-08: CDK4/6 inhibition is a potential vulnerability in NF1-depleted ER+ breast cancer

Ze-Yi Zheng, Anran Chen, Eric Jaehnig, Meenakshi Anurag, Jonathan Lei, Chenwei Wang, Long Feng, Purba Singh, Hilda Kennedy, Jin Cao, Ghazal Yadav, Jill Tsai, Xi Chen, Charles Foulds, Bora Lim, Matthew Ellis, Bing Zhang, Eric Chang
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): GS01-08.
https://doi.org/10.1158/1538-7445.SABCS23-GS01-08
Published: 02 May 2024
View article titled, Abstract GS01-08: CDK4/6 inhibition is a potential vulnerability in NF1-depleted ER+ breast cancer
Journal Articles

Abstract PO2-14-11: Proteogenomic approaches for the identification of NF1/neurofibromin-depleted estrogen receptor positive breast cancers for targeted treatment

Beom-Jun Kim, Ze-Yi Zheng, Jonathan Lei, Matthew Holt, Anran Chen, Jianheng Peng, Diana Fandino, Purba Singh, Hilda Kennedy, Yongchao Dou, M Rosario Chica-Parrado, Emmanuel Bikorimana, Dan Ye, Yunguan Wang, Ariella Hanker, Nada Mohamed, Susan Hilsenbeck, Bora Lim, Jaya Ruth Asirvatham, Arun Sreekumar, Bing Zhang, George Miles, Meenakshi Anurag, Matthew Ellis, Eric Chang
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO2-14-11.
https://doi.org/10.1158/1538-7445.SABCS23-PO2-14-11
Published: 02 May 2024
View article titled, Abstract PO2-14-11: Proteogenomic approaches for the identification of NF1/neurofibromin-depleted estrogen receptor positive breast cancers for targeted treatment
Journal Articles

Abstract LB213: NF1 loss promotes bone metastasis in estrogen receptor positive breast cancer

Zifan Zhao, Ze-Yi Zheng, Jonathan Lei, Matthew J. Baik, Yi-Hsuan Wu, Junkai Wang, Igor Bado, Meenakshi Anurag, Bing Zhang, Xiang Zhang, Eric Chang
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): LB213.
https://doi.org/10.1158/1538-7445.AM2024-LB213
Published: 05 April 2024
View article titled, Abstract LB213: NF1 loss promotes bone metastasis in estrogen receptor positive breast cancer
Journal Articles

Abstract LB004: Deciphering oncogenic dedifferentiation: A proteomic approach to quantifying stemness scores and unveiling druggable targets

Iga Kołodziejczak-Guglas, Renan Simões, Elizabeth G. Demicco, Rossana L. Segura, Alexander J. Lazar, Weiping Ma, Erik Storrs, Francesca Petralia, Antonio Colaprico, Felipe da Leprevost, Pietro Pugliese, Michele Ceccarelli, Alexey I. Nesvizhski, Bożena Kamińska, Bing Zhang, Henry Rodriguez, Mehdi Mesri, Ana I. Robles, Clinical Proteomic Tumor Analysis Consortium, Li Ding, Tathiane M. Malta, Maciej Wiznerowicz
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): LB004.
https://doi.org/10.1158/1538-7445.AM2024-LB004
Published: 05 April 2024
View article titled, Abstract LB004: Deciphering oncogenic dedifferentiation: A proteomic approach to quantifying stemness scores and unveiling druggable targets
Journal Articles

Abstract 1716: A proteome-wide association study identifies putative causal proteins for breast cancer

Tianying Zhao, Shuai Xu, Jie Ping, Guochong Jia, Yongchao Dou, Bing Zhang, Xingyi Guo, Qiuyin Cai, Xiao-Ou Shu, Wei Zheng, Jirong Long
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1716.
https://doi.org/10.1158/1538-7445.AM2024-1716
Published: 22 March 2024
View article titled, Abstract 1716: A proteome-wide association study identifies putative causal proteins for breast cancer
Journal Articles

Abstract 7354: Proteogenomic and metabolomic characterization of acute myeloid leukemia

Alec Chu, Yi Hsiao, Yamei Deng, Chenwei Wang, Jennifer Kyle, Yongchao Dou, James C. Pino, Camilo Posso, Leanne Henry, Lijun Chen, Ginny Xiaohe Li, Tung-Shing Mamie Lih, Yifat Geffen, Fengchao Yu, Li Ding, Gil Omenn, Chandan Kumar, Saravana M. Dhanasekaran, Elie Traer, Jeffrey W. Tyner, Hui Zhang, Tao Liu, Sara Gosline, Bing Zhang, Arul Chinnaiyan, Alexey I. Nesvizhskii, Marcin Cieslik, The CPTAC Consortium
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 7354.
https://doi.org/10.1158/1538-7445.AM2024-7354
Published: 22 March 2024
View article titled, Abstract 7354: Proteogenomic and metabolomic characterization of acute myeloid leukemia
Journal Articles

Abstract PR02: Modeling breast cancer through somatic precision gene editing with high flexibility and efficiency

Wen Bu, Yi Li, Chad J Creighton, Kelsey S Heavener, Carolina Gutierrez, Yongchao Dou, Weiyu Jiang, Bing Zhang, Amy T Ku, Shixia Huang
Journal: Cancer Research
Cancer Res (2024) 84 (3_Supplement_1): PR02.
https://doi.org/10.1158/1538-7445.ADVBC23-PR02
Published: 01 February 2024
View article titled, Abstract PR02: Modeling breast cancer through somatic precision gene editing with high flexibility and efficiency
Journal Articles

Abstract LB061: Proteomic-based stemness score measure oncogenic dedifferentiation and enable the identification of druggable targets

Tathiane M. Malta, Iga Kołodziejczak, Renan Simões, Antonio Colaprico, Erik Storrs, Francesca Petralia, Felipe da v Leprevost, Rossana L. Segura, Elizabeth Demicco, Alexander J. Lazar, Weiping Ma, Pietro Pugliese, Michele Ceccarelli, Bozena Kamińska, Alexey I. Nesvizhski, Bing Zhang, Henry Rodriguez, Mehdi Mesri, Ana I. Robles, Clinical Proteomic Tumor Analysis Consortium, Li Ding, Maciej Wiznerowicz
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): LB061.
https://doi.org/10.1158/1538-7445.AM2023-LB061
Published: 14 April 2023
View article titled, Abstract LB061: Proteomic-based stemness score measure oncogenic dedifferentiation and enable the identification of druggable targets
Journal Articles

Abstract 6575: LinkedOmicsKB: A web portal to explore pan-cancer molecular and phenotype associations

Sara R. Savage, Yuxing Liao, Yongchao Dou, Zhiao Shi, Xinpei Yi, Wen Jiang, Jonathan T. Lei, Bing Zhang
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6575.
https://doi.org/10.1158/1538-7445.AM2023-6575
Published: 04 April 2023
View article titled, Abstract 6575: LinkedOmicsKB: A web portal to explore pan-cancer molecular and phenotype associations
Journal Articles

Abstract 5726: Pan-cancer proteogenomics expands the landscape of therapeutic targets

Jonathan T. Lei, Sara R. Savage, Xinpei Yi, Bo Wen, Hongwei Zhao, Lauren K. Somes, Paul W. Shafer, Yongchao Dou, Qiang Gao, Valentina Hoyos, Bing Zhang
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5726.
https://doi.org/10.1158/1538-7445.AM2023-5726
Published: 04 April 2023
View article titled, Abstract 5726: Pan-cancer proteogenomics expands the landscape of therapeutic targets
Journal Articles

Abstract 5717: Bridging the gap between clinical-omics and machine learning to improve cancer treatment

Chang In Moon, Byron Jia, Bing Zhang
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5717.
https://doi.org/10.1158/1538-7445.AM2023-5717
Published: 04 April 2023
View article titled, Abstract 5717: Bridging the gap between clinical-omics and machine learning to improve cancer treatment
Journal Articles

Abstract 4492: A novel and potent FLT3 and IRAK4 dual inhibitor for the treatment of acute myeloid leukemia

Rui Yang, Lei Wu, Bing Zhang, Michael Xiang, Suyue Wang, Camille Xiang, Zhijian Lu, Jason Xiang
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4492.
https://doi.org/10.1158/1538-7445.AM2023-4492
Published: 04 April 2023
View article titled, Abstract 4492: A novel and potent FLT3 and IRAK4 dual inhibitor for the treatment of acute myeloid leukemia
Journal Articles

Abstract 955: Proteogenomic insights suggest druggable pathways in endometrial cancer

Lizabeth Katsnelson, Yongchao Dou, Marina A. Gritsenko, Matthew L. Anderson, Karin D. Rodland, Bing Zhang, Tao Liu, David Fenyö, the Clinical Proteomic Tumor Analysis Consortium
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 955.
https://doi.org/10.1158/1538-7445.AM2023-955
Published: 04 April 2023
View article titled, Abstract 955: Proteogenomic insights suggest druggable pathways in endometrial cancer
Journal Articles

Abstract 2023: CoPheeMap: a co-regulation map of 30,000 phosphosite illuminates the dark cancer phosphoproteome

Wen Jiang, Eric Jaehnig, Bing Zhang
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 2023.
https://doi.org/10.1158/1538-7445.AM2023-2023
Published: 04 April 2023
View article titled, Abstract 2023: CoPheeMap: a co-regulation map of 30,000 phosphosite illuminates the dark cancer phosphoproteome
Journal Articles

Abstract P2-12-02: ClinicalomicsDB - Bridging the gap between clinical omics data and machine learning

Chang In Moon, Byron Jia, Bing Zhang
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P2-12-02.
https://doi.org/10.1158/1538-7445.SABCS22-P2-12-02
Published: 01 March 2023
View article titled, Abstract P2-12-02: ClinicalomicsDB - Bridging the gap between clinical omics data and machine learning
Journal Articles

Abstract P5-02-36: Proteogenomic profiling of fresh frozen core biopsies from CALGB 40601

Eric J. Jaehnig, Aranzazu Fernandez-Martinez, Tanmayi Vashist, Matthew V. Holt, LaTerrica Williams, Jonathan Lei, Beom-Jun Kim, Yongchao Dou, Viktoriya Korchina, Richard Gibbs, Donna Muzny, Harshavardhan Doddapaneni, Henry Rodriguez, Ana Robles, Tara Hiltke, DR Mani, Michael Gillette, Terry Hyslop, Yujia Wen, Linda McCart, George Miles, Steven Carr, Bing Zhang, Shankha Satpathy, Matthew Ellis, Meenakshi Anurag
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P5-02-36.
https://doi.org/10.1158/1538-7445.SABCS22-P5-02-36
Published: 01 March 2023
View article titled, Abstract P5-02-36: Proteogenomic profiling of fresh frozen core biopsies from CALGB 40601
Journal Articles

Abstract PD5-05: PD5-05 DAPK3 modulates migration and invasion of triple negative breast cancers

Junkai Wang, Beom-Jun Kim, Meenakshi Anurag, Xin Yu, Xiaoli Qi, Jin Wang, Bing Zhang, Chonghui Cheng, Matthew Ellis
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): PD5-05.
https://doi.org/10.1158/1538-7445.SABCS22-PD5-05
Published: 01 March 2023
View article titled, Abstract PD5-05: PD5-05 DAPK3 modulates migration and invasion of triple negative breast cancers
Journal Articles

Abstract P2-23-01: Patient-derived xenografts allow deconvolution of single agent and combination chemotherapy responses in triple-negative breast cancer

Jonathan T. Lei, Chen Huang, Ramakrishnan R. Srinivasan, Suhas Vasaikar, Lacey E. Dobrolecki, Alaina N. Lewis, Na Zhao, Jin Cao, Susan G. Hilsenbeck, C. Kent Osborne, Mothaffar Rimawi, Matthew J. Ellis, Varduhi Petrosyan, Alexander B. Saltzman, Anna Malovannaya, John D. Landua, Bo Wen, Antrix Jain, Gerburg M. Wulf, Shunqiang Li, Daniel C. Kraushaar, Tao Wang, Xi Chen, Gloria V. Echeverria, Meenakshi Anurag, Bing Zhang, Michael T. Lewis
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P2-23-01.
https://doi.org/10.1158/1538-7445.SABCS22-P2-23-01
Published: 01 March 2023
View article titled, Abstract P2-23-01: Patient-derived xenografts allow deconvolution of single agent and combination chemotherapy responses in triple-negative breast cancer